NEW YORK, Feb 26 (Reuters) - Eli Lilly and Co. said on Monday that the U.S. Food and Drug Administration has added treatment of generalized anxiety disorder to the approved uses for the drugmaker's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results